{"id":"W2914108875","doi":"10.1016/j.ctrv.2019.02.001","title":"Network meta-analysis of therapies for previously untreated advanced BRAF-mutated melanoma","year":2019,"lang":"en","type":"review","venue":"Cancer Treatment Reviews","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; Impact","funders":"","keywords":"Medicine; Dabrafenib; Vemurafenib; Trametinib; Dacarbazine; Oncology; Internal medicine; Ipilimumab; Melanoma; Hazard ratio; Nivolumab; Randomized controlled trial; Population; Progression-free survival; Metastatic melanoma; Cancer; Immunotherapy; Chemotherapy; Cancer research; Overall survival; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003248981,0.001263376,0.004352498,0.0009895354,0.0001152357,0.000800622,0.0008657574,0.0005936137,0.003327341],"category_scores_gemma":[0.007516473,0.0003414374,0.009451126,0.001722079,0.0001373714,0.0004820422,0.00058675,0.001190663,0.0002439552],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008588965,"about_ca_system_score_gemma":0.0009906669,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003712512,"about_ca_topic_score_gemma":0.01080084,"domain_scores_codex":[0.9982076,0.001131258,0.0001875352,0.0002444292,0.0001669658,0.00006222084],"domain_scores_gemma":[0.9959192,0.003288939,0.0004163622,0.0001335157,0.0001752977,0.00006672683],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.007042921,0.00007515756,0.01072602,0.1193847,0.4963322,0.0001362937,0.00005685045,0.006398163,0.0008507258,0.001275851,0.0193505,0.3383705],"study_design_scores_gemma":[0.002257872,0.000856916,0.04008421,0.01953382,0.8758034,0.0003656628,0.00006700597,0.003906976,0.0006142698,0.006747453,0.0496607,0.0001018124],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.002944112,0.9940461,0.0008071962,0.0005430551,0.0002387197,0.00002321871,0.0009081113,0.00002476368,0.0004647193],"genre_scores_gemma":[0.121936,0.870844,0.002184312,0.001322015,0.000767372,0.0001385103,0.002160602,0.00004421702,0.0006029361],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004352498,"threshold_uncertainty_score":0.01718241,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2066071400116449,"score_gpt":0.3974582458880378,"score_spread":0.1908511058763929,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}